Pinelopi Samara

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Diffuse Large B Cell Lymphoma

Loop Mediated Isothermal Amplification

Top Venues

Methods and protocols

Exploration of targeted anti-tumor therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Michalis Athanasopoulos, Pinelopi Samara, Ioannis Athanasopoulos
Advances in 3D Inner Ear Reconstruction Software for Cochlear Implants: A Comprehensive Review. Methods and protocols 7 (3) (2024)
Pinelopi Samara, Michalis Athanasopoulos, Stylianos Mastronikolis, Efthymios Kyrodimos, Ioannis Athanasopoulos, Nicholas S Mastronikolis
The Role of Oncogenic Viruses in Head and Neck Cancers: Epidemiology, Pathogenesis, and Advancements in Detection Methods. Microorganisms 12 (7) (2024)
Pinelopi Samara, Michalis Athanasopoulos, Stylianos Mastronikolis, Efthymios Kyrodimos, Ioannis Athanasopoulos, Nicholas S Mastronikolis
The Role of Oncogenic Viruses in Head and Neck Cancers: Epidemiology, Pathogenesis, and Advancements in Detection Methods. Microorganisms 12 (7) (2024)
Michalis Athanasopoulos, Pinelopi Samara, Ioannis Athanasopoulos
Advances in 3D Inner Ear Reconstruction Software for Cochlear Implants: A Comprehensive Review. Methods and protocols 7 (3) (2024)
Pinelopi Samara, Michalis Athanasopoulos, Stylianos Mastronikolis, Efthymios Kyrodimos, Ioannis Athanasopoulos, Nicholas S Mastronikolis
The Role of Oncogenic Viruses in Head and Neck Cancers: Epidemiology, Pathogenesis, and Advancements in Detection Methods. Microorganisms 12 (7) (2024)
Michalis Athanasopoulos, Pinelopi Samara, Ioannis Athanasopoulos
Advances in 3D Inner Ear Reconstruction Software for Cochlear Implants: A Comprehensive Review. Methods and protocols 7 (3) (2024)
Pinelopi Samara, Michalis Athanasopoulos, Anastasios K Goulioumis, Ioannis Athanasopoulos
Malignant tumors of the external auditory canal: diagnosis, treatment, genetic landscape, biomarkers, and clinical outcome. Exploration of targeted anti-tumor therapy 4 (5) (2023)